Rivastigmine Sandoz 9.5mg / 24 hours Transdermal Patch

Licence status
Withdrawn: 14/07/2022
Active substances
Rivastigmine
Dosage Form
Transdermal patch
Licence number
PA0711/222/002
Licence holder
Rowex Ltd

Product documents

Licence information

ATC code
N06DA Anticholinesterases, N06DA03 rivastigmine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
The MAH have committed to submitting a variation to register an invented name (as per the IMB Guide to Invented Names) prior to marketing this product.
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
20/12/2013

Educational materials for patients